Treatment of Osteoporosis

Based on a combination of bone mineral density (BMD) and risk factors of the patient.

Indicated in patients with:

• All postmenopausal women who have had an osteoporotic vertebral fracture.
• BMD values consistent with osteporosis ( T-score worse than or equal to -2.5).
• BMD values T-score from -2.0 to -2.5 plus at least one of the following risk factors for fracture: thinness, history of fragility fracture (other than skull, facial bone, ankle, finger and toe) since menopause, and history of hip fracture in a patient.

Drugs used are:

Bisphosphonates are the first-line drugs for treating postmenopausal women with osteoporosis. Alendronate and risedronate reduce the risk for both vertebral and non vertebral fractures.